JPS63284174A - キノリジノン化合物およびその製造法 - Google Patents

キノリジノン化合物およびその製造法

Info

Publication number
JPS63284174A
JPS63284174A JP63100967A JP10096788A JPS63284174A JP S63284174 A JPS63284174 A JP S63284174A JP 63100967 A JP63100967 A JP 63100967A JP 10096788 A JP10096788 A JP 10096788A JP S63284174 A JPS63284174 A JP S63284174A
Authority
JP
Japan
Prior art keywords
group
formula
salt
compound
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63100967A
Other languages
English (en)
Japanese (ja)
Other versions
JPH039113B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Yoshihiko Kitaura
良彦 北浦
Teruo Oku
照夫 奥
Hideo Hirai
平井　英雄
Toshiyuki Yamamoto
山本　寿幸
Shinji Hashimoto
眞志 橋本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848408292A external-priority patent/GB8408292D0/en
Priority claimed from GB848429710A external-priority patent/GB8429710D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS63284174A publication Critical patent/JPS63284174A/ja
Publication of JPH039113B2 publication Critical patent/JPH039113B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP63100967A 1984-03-30 1988-04-22 キノリジノン化合物およびその製造法 Granted JPS63284174A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB848408292A GB8408292D0 (en) 1984-03-30 1984-03-30 Quinolizinone compound
GB8408292 1984-03-30
GB848429710A GB8429710D0 (en) 1984-11-23 1984-11-23 Pharmaceutical composition
GB8429710 1984-11-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP60067788A Division JPS60222482A (ja) 1984-03-30 1985-03-29 キノリジノン化合物またはその塩を含有する抗アレルギー剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP63312576A Division JPH0649701B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-03-30 1988-12-09

Publications (2)

Publication Number Publication Date
JPS63284174A true JPS63284174A (ja) 1988-11-21
JPH039113B2 JPH039113B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-02-07

Family

ID=26287537

Family Applications (4)

Application Number Title Priority Date Filing Date
JP63100967A Granted JPS63284174A (ja) 1984-03-30 1988-04-22 キノリジノン化合物およびその製造法
JP63312576A Pending JPH0649701B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-03-30 1988-12-09
JP63312576A Pending JPH01193268A (ja) 1984-03-30 1988-12-09 キノリジノン化合物およびその製法
JP1133926A Granted JPH0215029A (ja) 1984-03-30 1989-05-25 キノリジノン化合物またはその塩を含有する抗潰瘍剤

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP63312576A Pending JPH0649701B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-03-30 1988-12-09
JP63312576A Pending JPH01193268A (ja) 1984-03-30 1988-12-09 キノリジノン化合物およびその製法
JP1133926A Granted JPH0215029A (ja) 1984-03-30 1989-05-25 キノリジノン化合物またはその塩を含有する抗潰瘍剤

Country Status (4)

Country Link
US (2) US4650804A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0157346B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (4) JPS63284174A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3575724D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889848A (en) * 1984-11-06 1989-12-26 Hoffmann-La Roche Inc. Tricyclic pyridine derivatives
CA1317945C (en) * 1985-12-13 1993-05-18 Ulf Fischer Tricyclic pyridazopyridone derivatives
US4877795A (en) * 1987-01-30 1989-10-31 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds useful for the treatment of allergic bronchial asthma, allergic rhinitis atropic dermatitis and the like
EP0294599A3 (de) * 1987-06-12 1990-05-09 F. Hoffmann-La Roche Ag Tricyclische Pyridonderivate
US4806525A (en) * 1987-06-18 1989-02-21 Mavi S.R.L. Formulation comprising gelatin and glycine for treating the dryness of skin
ZA885263B (en) * 1987-07-28 1989-03-29 Fujisawa Pharmaceutical Co Crystalline monohydrate of sodium n-(1h-tetrazol-5-yl)-1-phenoxy-4h-quinolizin-4-one-3-carboxamide
US4921857A (en) * 1987-09-18 1990-05-01 Merck & Co., Inc. 4-Oxo-4h-quinolizine-3-carboxylic acids and derivatives thereof
US4904657A (en) * 1987-09-24 1990-02-27 Kissei Pharmaceutical Co., Ltd. 4H-quinolizin-4-one compounds exhibiting therapeutic activities
AU616916B2 (en) * 1987-11-20 1991-11-14 Kissei Pharmaceutical Co. Ltd. 4h-quinolizin-4-one compounds exhibiting therapeutic activities
US4940715A (en) * 1988-05-17 1990-07-10 Kissei Pharmaceutical Co., Ltd. 5H-pyrazolo[4,3-A] quinolizin-5-one compounds exhibiting therapeutic activities
IE911472A1 (en) * 1990-05-02 1991-11-06 Abbott Lab Quinolizinone type compounds
US5726182A (en) * 1990-05-02 1998-03-10 Abbott Laboratories Quinolizinone type compounds
US5643920A (en) * 1992-04-27 1997-07-01 Mochida Pharmaceutical Co., Ltd. Tricyclic compound having anti-allergic activities
WO1994013289A1 (fr) * 1992-12-10 1994-06-23 Tsentr Po Khimii Lekarstvennykh Sredstv Compose pharmaceutique a proprietes antiulcereuses
FI960157A7 (fi) * 1993-07-13 1996-01-12 Janssen Pharmaceutica Nv Allergianvastaisia imidatsoatsepiineja
US5869500A (en) * 1996-12-13 1999-02-09 Hoffmann-La Roche Inc. Pyridone compounds useful in treating Alzheimer's disease
HK1040076A1 (zh) 1998-09-21 2002-05-24 希雷生物化学有限公司 作为整联蛋白抑制剂的喹嗪酮
US6706528B2 (en) * 2000-03-24 2004-03-16 The United States Of America As Represented By The Department Of Health And Human Services Fluorescent magnesium indicators
PT2465537T (pt) 2002-10-10 2016-08-03 Ono Pharmaceutical Co Microsferas compreendendo ono-1301
US7745459B2 (en) * 2004-09-21 2010-06-29 Japan Tobacco Inc. Quinolizinone compound and use thereof as HIV integrase inhibitor
WO2006110477A2 (en) * 2005-04-07 2006-10-19 Astrum Therapeutics Pty. Ltd. Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus
MX2007014114A (es) 2005-05-10 2008-03-14 Intermune Inc Derivados de piridona para modular el sistema de proteina cinasa activada por estres.
KR100785088B1 (ko) 2006-05-23 2007-12-12 한국과학기술연구원 두 개의 엑소 메틸렌을 가지는 고리가 접합된 락탐화합물과이의 제조방법
TW200838534A (en) 2007-02-07 2008-10-01 Astellas Pharma Inc Treatment for irritable bowel syndrome
CA2712946A1 (en) * 2008-02-13 2009-08-20 Merck Sharp & Dohme Corp. Quinolizidinone m1 receptor positive allosteric modulators
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
CA2738812A1 (en) * 2008-10-06 2010-04-15 Merck Sharp & Dohme Corp. Quinolizidinone m1 receptor positive allosteric modulators
US8754220B2 (en) * 2009-11-20 2014-06-17 Merck Sharp & Dohme Corp. Quinolizidinone carboxamide M1 receptor positive allosteric modulators
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN110452216B (zh) 2014-04-02 2022-08-26 英特穆恩公司 抗纤维化吡啶酮类

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1433151A (en) * 1973-04-05 1976-04-22 Allen & Hanburys Ltd Benzo-ij-quinolizines
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation

Also Published As

Publication number Publication date
JPH0649701B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-06-29
JPH039113B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-02-07
US4650804A (en) 1987-03-17
JPH039088B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-02-07
EP0157346A2 (en) 1985-10-09
DE3575724D1 (de) 1990-03-08
EP0157346A3 (en) 1986-02-05
JPH0215029A (ja) 1990-01-18
EP0157346B1 (en) 1990-01-31
US4698349A (en) 1987-10-06
JPH01193268A (ja) 1989-08-03

Similar Documents

Publication Publication Date Title
JPS63284174A (ja) キノリジノン化合物およびその製造法
CN101228161B (zh) 适用作蛋白激酶抑制剂的吡咯并吡啶类
JP2763036B2 (ja) 複素環化合物
JP3572617B2 (ja) ピラゾロピリジンアデノシン拮抗剤
JPS63280078A (ja) ヘテロニ環式キノロン誘導体
JPH0334979A (ja) １０―デアザミノプテリンおよびその１０―アルキル誘導体の製造方法
JPH1087629A (ja) 新規イソキノリン誘導体、およびその医薬用途
US4782055A (en) Imidazopyridine compounds useful in the treatment of ulcers
JPH11508267A (ja) ピラゾール化合物および医薬組成物
JP4825387B2 (ja) 新規な１，８−ナフチリジン−２（１ｈ）−オン誘導体
JPH0739391B2 (ja) Ｎ−含有複素環化合物
US3661903A (en) Halo-substituted 2-amino-benzylamine-morpholides and salts thereof
JPS6110584A (ja) イミダゾイソキノリン化合物およびその製造方法
JPS61152682A (ja) ピリドンカルボン酸誘導体、そのエステルおよびその塩
JPS60222482A (ja) キノリジノン化合物またはその塩を含有する抗アレルギー剤
JPS6089480A (ja) ピリドンカルボン酸誘導体
JPS6028978A (ja) １，８−ナフチリジン誘導体
JPS61137885A (ja) １，８−ナフチリジン誘導体、そのエステルおよびその塩
AU598446B2 (en) Quinolizinone compound, processes for preparation thereof and pharmaceutical composition comprising the same
KR930001413B1 (ko) 퀴놀리지논 화합물의 제조방법
JPS62135473A (ja) イミダゾ−ル縮合複素環化合物
JPH107571A (ja) 肺癌治療におけるナフタレン誘導体の使用
JPH0568477B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS62135458A (ja) 新規キノロン化合物およびその製造法
US4256753A (en) 4-(2-Pyridylamino)phenylacetic acid derivatives

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees